Skip to main content
. 2018 Sep 10;2018(9):CD007287. doi: 10.1002/14651858.CD007287.pub4

NCT00004604.

Trial name or title Biological therapy in treating patients with metastatic cancer
Methods Uncontrolled phase I
Participants 24 participants with histologically confirmed metastatic adenocarcinoma expressing carcinoembryonic antigen (CEA) who has failed conventional therapy
Interventions Intravenous CEA RNA‐pulsed autologous dendritic cells
Outcomes Adverse events
Immune responses
Clinical and biochemical responses
Starting date February 1998
Contact information  
Notes Completed July 2002; no publication available